特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
140085

米国の造影剤および放射性医薬品市場分析:2019年

Contrast Agents and Radiopharmaceuticals | Market Analysis | US | 2019

出版日: | 発行: Decision Resources Group - Medtech | ページ情報: 英文 72 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=106.37円
米国の造影剤および放射性医薬品市場分析:2019年
出版日: 2018年07月23日
発行: Decision Resources Group - Medtech
ページ情報: 英文 72 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 目次
概要

米国市場における造影剤および放射性医薬品の成長は、CEUSおよびPET処置における造影剤の使用の拡大によって推進されます。しかし、モダリティによってはガドリニウムおよび放射線被ばくといった健康への影響が起こるという不安定要素によって幾分成長が限定されるでしょう。また、バリューベースケア(患者の選好・価値観に基づく医療)への移行が、最も精密で鮮明な画像を提供する診断方法の活用を支持している一方で、その利用を妨げることにもなります。

当レポートでは、米国における造影剤および放射性医薬品市場全体、およびセグメント別市場の概要と分析、競合の分析などを提供しています。

第1章 造影剤および放射性医薬品市場

  • 市場ハイライト
  • 市場の定義
  • 市場予測データ
  • 全般的市場動向
  • 競合ハイライト
  • 市場シェア
  • 市場発展
  • 競合因子と戦略

第2章 放射性医薬品市場

  • 市場ハイライト
  • 市場の定義
  • 市場予測データ
    • SPECT
    • PET
  • 全般的市場動向
  • 競合ハイライト
  • 市場シェア
  • 競合因子と戦略

第3章 CTおよびX線造影剤市場

  • 市場ハイライト
  • 市場の定義
  • 市場予測データ
    • CT
    • 心血管用X線
    • 一般的X線
  • 全般的市場動向
  • 競合ハイライト
  • 市場シェア
  • 競合因子と戦略

第4章 MRI造影剤市場

  • 市場ハイライト
  • 市場の定義
  • 市場予測データ
  • 全般的市場動向
  • 競合ハイライト
  • 市場シェア
  • 競合因子と戦略

第5章 超音波造影剤市場

  • 市場ハイライト
  • 市場の定義
  • 市場予測データ
  • 全般的市場動向
  • 競合ハイライト
  • 市場シェア
  • 競合因子と戦略

調査方法

付録

目次
Product Code: M360RP0010

Growth in the US market for contrast agents and radiopharmaceuticals will be driven by the expanded use of imaging agents in CEUS and PET procedures. However, the market will be somewhat limited by the continued concern over gadolinium and radiation exposure in certain modalities, while the shift to value-based care will hinder the use of some procedures while supporting the use of those that provide the most accuracy and clarity of visualization.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for contrast agents and radiopharmaceuticals in the US across a 10-year period.

The FDA recently expanded approval for the use of CEUS in radiology procedures.

  • What types of procedures does this approval extend to? Which additional procedures could be approved in the future?
  • Which contrast agents received FDA approval?
  • How will competitors that do not have FDA approval react?

Looming concerns over the effects of gadolinium retention will negatively affect the use of contrast-enhanced MRI.

  • How are ACOs, health networks, and physicians responding to the recent findings on gadolinium retention?
  • What are the key differences between linear and macrocyclic GBCAs, and how will market demand for these products shift going forward?
  • Will other imaging modalities cannibalize contrast-enhanced MRI procedures?

While less concerning than in the past, radiation dose concerns still exert a limiting effect on procedure volumes for some imaging modalities.

  • How are US radiologists responding, and what methods are they using to ensure image quality?
  • Which procedures are being cannibalized by other modalities that do not require radiation for image acquisition?

The SPECT radiopharmaceuticals industry is taking precautionary measures to insulate itself from the shortening supply of Mo-99 and Tc-99.

  • What novel technology is showing promise that could help with global supply of Tc-99?
  • How will the transition from HEU to LEU reactors affect ASPs in the US market?

Table of Contents

Table of Contents

Tables and Figures

Executive Summary

Version History

1. Contrast Agent and Radiopharmaceutical Market

  • 1.1. Market Highlights
  • 1.2. Market Definitions
  • 1.3. Market Forecast Data
  • 1.4. General Market Trends
  • 1.5. Competitive Highlights
  • 1.6. Market Shares
  • 1.7. Competitive Factors and Strategies
  • 1.8. Market Developments

2. Radiopharmaceutical Market

  • 2.1. Market Highlights
  • 2.2. Market Definitions
  • 2.3. Market Forecast Data
  • 2.4. General Market Trends
  • 2.5. Competitive Highlights
  • 2.6. Market Shares
  • 2.7. Competitive Factors and Strategies

3. CT and X-Ray Contrast Agent Market

  • 3.1. Market Highlights
  • 3.2. Market Definitions
  • 3.3. Market Forecast Data
  • 3.4. General Market Trends
  • 3.5. Competitive Highlights
  • 3.6. Market Shares
  • 3.7. Competitive Factors and Strategies

4. MRI Contrast Agent Market

  • 4.1. Market Highlights
  • 4.2. Market Definitions
  • 4.3. Market Forecast Data
  • 4.4. General Market Trends
  • 4.5. Competitive Highlights
  • 4.6. Market Shares
  • 4.7. Competitive Factors and Strategies

5. Ultrasound Contrast Agent Market

  • 5.1. Market Highlights
  • 5.2. Market Definitions
  • 5.3. Market Forecast Data
  • 5.4. General Market Trends
  • 5.5. Competitive Highlights
  • 5.6. Market Shares
  • 5.7. Competitive Factors and Strategies

Methodology

  • Core Country Coverage Methodology
  • Supplemental Country Coverage Methodology

Appendix: Acronyms and Initialisms

Appendix: Bibliography

Tables and Figures

  • Table 1: Factors Impacting the Contrast Agent and Radiopharmaceutical Market, by Product Type, US
  • Figure 1: Contrast Agent and Radiopharmaceutical Market, by Product Type, US (USD), 2017--2027
  • Table 2: Contrast Agent and Radiopharmaceutical Market Landscape, US (USD), 2018 and 2027
  • Table 3: Competitive Factors and Strategies, by Product Type, US
  • Table 4: Contrast Agent and Radiopharmaceutical Market Share Rankings, by Product Type, US, 2018
  • Table 5: Companies Mentioned
  • Table 6: Recent Events in the Contrast Agent and Radiopharmaceutical Market, US
  • Table 7: Emerging Products for the Contrast Agent and Radiopharmaceutical Market, US
  • Table 8: Contrast Agent and Radiopharmaceutical Procedures and Products Covered, US
  • Table 9: Version History
  • Table 10: Factors Impacting the Contrast Agent and Radiopharmaceutical Market, by Product Type, US
  • Figure 2: Contrast Agent and Radiopharmaceutical Market, by Product Type, US (USD), 2017--2027
  • Table 11: Contrast Agent and Radiopharmaceutical Procedures, by Product Type, US, 2017--2027
  • Table 12: Contrast Agent and Radiopharmaceutical Market, by Product Type, US (USD), 2017--2027
  • Figure 3: Contrast Agent and Radiopharmaceutical Revenue Market Shares, US, 2018
  • Table 13: Contrast Agent and Radiopharmaceutical Revenue Market Shares, by Product Type, US, 2018
  • Table 14: Competitive Factors and Strategies, by Product Type, US
  • Table 15: Recent Events in the Contrast Agent and Radiopharmaceutical Market, US
  • Table 16: Emerging Products for the Contrast Agent and Radiopharmaceutical Market, US
  • Figure 4: Radiopharmaceutical Market, by Product Type, US (USD), 2017--2027
  • Table 17: Radiopharmaceutical Market, by Product Type, US (USD), 2017--2027
  • Table 18: Radiopharmaceutical Market Growth, by Product Type, US, 2018--2027
  • Table 19: Nuclear Medicine System Installed Base, by Product Type, US, 2017--2027
  • Figure 5: Radiopharmaceutical Revenue Market Shares, US, 2018
  • Table 20: Radiopharmaceutical Revenue Market Shares, by Product Type, US, 2018
  • Table 21: Competitive Factors and Strategies, US
  • Figure 6: CT and X-Ray Contrast Agent Market, by Product Type, US (USD), 2017-- 2027
  • Table 22: CT and X-Ray Contrast Agent Market, by Product Type, US (USD), 2017-- 2027
  • Table 23: CT and X-Ray Contrast Agent Market Growth, by Product Type, US, 2018-- 2027
  • Table 24: CT and X-Ray System Installed Base, by Product Type, US, 2017--2027
  • Table 25: CT Contrast Agent Market, by Procedure Type, US (USD), 2017--2027
  • Table 26: CT Contrast Agent Market Growth, by Procedure Type, US, 2018--2027
  • Figure 7: CT and X-Ray Contrast Agent Revenue Market Shares, US, 2018
  • Table 27: CT and X-Ray Contrast Agent Revenue Market Shares, US, 2018
  • Table 28: Competitive Factors and Strategies, US
  • Figure 8: MRI Contrast Agent Market, by Procedure Type, US (USD), 2017--2027
  • Table 29: MRI Contrast Agent Market, by Procedure Type, US (USD), 2017--2027
  • Table 30: MRI Contrast Agent Market Growth, by Procedure Type, US, 2018--2027
  • Table 31: MRI System Installed Base, US, 2017--2027
  • Figure 9: MRI Contrast Agent Revenue Market Shares, US, 2018
  • Table 32: MRI Contrast Agent Revenue Market Shares, US, 2018
  • Table 33: Competitive Factors and Strategies, US
  • Figure 10: Ultrasound Contrast Agent Market, US (USD), 2017--2027
  • Table 34: Ultrasound Contrast Agent Market, US (USD), 2017--2027
  • Figure 11: Ultrasound Contrast Agent Revenue Market Shares, US, 2018
  • Table 35: Ultrasound Contrast Agent Revenue Market Shares, US, 2018
  • Table 36: Competitive Factors and Strategies, US
  • Table 37: Acronyms and Initialisms
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.